We are live on
!
Find out more
QC
Quantessence Capital Portfolio holdings
AUM
$20.5M
1-Year Est. Return
71.02%
This Fund
S&P 500
This Quarter
Est. Return
+14.43%
1 Year Est. Return
+71.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$60.2M
(-15%)
Cap. Flow
-$87.3M
Cap. Flow
% of AUM
-25.71%
Top 10 Holdings %
Top 10 Hldgs %
46.41%
Holding
483
New
151
Increased
11
Reduced
18
Closed
302
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AZEK
The AZEK Co
AZEK
|
+$58.6M |
| 2 |
RDFN
Redfin
RDFN
|
+$35.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$8.53M |
| 4 |
Sprouts Farmers Market
SFM
|
+$7.45M |
| 5 |
Insmed
INSM
|
+$5.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$30.3M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$12.3M |
| 3 |
ExxonMobil
XOM
|
+$11.3M |
| 4 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$10.8M |
| 5 |
Pfizer
PFE
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 31.47% |
| 2 | Real Estate | 13.23% |
| 3 | Healthcare | 10.04% |
| 4 | Financials | 9.26% |
| 5 | Consumer Discretionary | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
CSX Corp
CSX
$94.3B
| $738K | 0.22% |
+22,605
| New | +$680K |
|
102
Elevance Health
ELV
$80.9B
| $673K | 0.2% |
1,729
-771
| -31% | -$310K |
|
103
Brookfield Infrastructure
BIPC
$4.99B
| $672K | 0.2% |
+16,146
| New | +$622K |
|
104
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.3B
| $668K | 0.2% |
+6,146
| New | +$628K |
|
105
InMode
INMD
$889M
| $667K | 0.2% |
+46,222
| New | +$678K |
|
106
Emcor
EME
$33.1B
| $661K | 0.19% |
+1,236
| New | +$545K |
|
107
HF Sinclair
DINO
$16B
| $628K | 0.18% |
+15,285
| New | +$526K |
|
108
Carrier Global
CARR
$57.1B
| $628K | 0.18% |
8,579
-23,021
| -73% | -$1.56M |
|
109
Starbucks
SBUX
$120B
| $597K | 0.18% |
+6,510
| New | +$564K |
|
110
Skyworks Solutions
SWKS
$8.93B
| $584K | 0.17% |
+7,842
| New | +$523K |
|
|
IPG
111
DELISTED
Interpublic Group of Companies
IPG
| $575K | 0.17% |
+23,501
| New | +$572K |
|
112
Bio-Rad Laboratories Class A
BIO
$8.15B
| $564K | 0.17% |
+2,336
| New | +$552K |
|
113
Teradyne
TER
$50.5B
| $559K | 0.16% |
+6,216
| New | +$497K |
|
114
Shopify
SHOP
$160B
| $556K | 0.16% |
+4,823
| New | +$482K |
|
115
XPO
XPO
$25.2B
| $526K | 0.15% |
4,165
-5,639
| -58% | -$633K |
|
116
iShares Mortgage Real Estate ETF
REM
$559M
| $502K | 0.15% |
+23,470
| New | +$493K |
|
117
Entegris
ENTG
$21.1B
| $496K | 0.15% |
+6,150
| New | +$467K |
|
118
Sociedad Química y Minera de Chile
SQM
$19.9B
| $485K | 0.14% |
+13,757
| New | +$470K |
|
119
Pool Corp
POOL
$7.33B
| $484K | 0.14% |
+1,662
| New | +$503K |
|
120
Fox Class B
FOX
$21.7B
| $476K | 0.14% |
+9,210
| New | +$448K |
|
121
StoneCo
STNE
$2.71B
| $473K | 0.14% |
29,461
-112,711
| -79% | -$1.5M |
|
122
iShares US Real Estate ETF
IYR
$4.83B
| $439K | 0.13% |
4,632
+1,138
| +33% | +$106K |
|
123
Dropbox
DBX
$7.14B
| $435K | 0.13% |
+15,227
| New | +$431K |
|
124
BCE
BCE
$20.4B
| $415K | 0.12% |
+18,700
| New | +$409K |
|
125
Unum
UNM
$14.2B
| $411K | 0.12% |
+5,093
| New | +$402K |
|
Similar funds
FS
HIIL
BC
PMAM
LFA
HAM
DP
SPC
Quantessence Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Quantessence Capital held 483 positions worth $340M, down 15% from $400M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Quantessence Capital withdrew a net $87.3M in Q2 2025, closing 302 positions and reducing 18 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $30.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 11% a quarter earlier, followed by Real Estate and Healthcare.
Against the trend, Quantessence Capital opened a new position in The AZEK Co worth $63.6M.
- Quantessence Capital's largest Q2 2025 buy was The AZEK Co: 1,170,131 shares worth $63.6M.
- Quantessence Capital added most to Merck in Q2 2025, an estimated $3.19M increase.
- Quantessence Capital's biggest Q2 2025 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $1.84M.
- Quantessence Capital fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $30.3M.
- Quantessence Capital's ten largest holdings make up 46% of its $340M portfolio in Q2 2025.
- Quantessence Capital opened 151 new positions and closed 302 in Q2 2025.
- Quantessence Capital's portfolio value fell 15% quarter-over-quarter to $340M.
Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.